[I’ve stopped maintaining this page. Please check Google Scholar.]

Below is a list of all my proper publications (peer-reviewed or otherwise). See the ‘Presentations‘ page for material relating to conferences and seminars. Gold (original version) and green (archived version) links mean open access. Red means you’ll probably hit a paywall.

2021

Health opportunity costs and expert elicitation: a comment on Soares et al. Medical Decision Making DOI: 10.1177/0272989X20987211 [PDF (pre-print)] (with Firth, I., and Towse, A.)

2020

Drop dead: is anchoring at ‘dead’ a theoretical requirement in health state valuation? OHE Research Paper. [RePEc] (with Parkin, D. and Devlin, N.)

Use of pharmacoeconomics in drug reimbursement: what can we learn from international experience? In R. Arnold (Eds.) Pharmacoeconomics: From Theory to Practice (pp. 241-253). CRC Press. DOI: 10.1201/9780429491368-14 (with Neri, M., and Zhang, K.)

2019

Transparency in decision modelling: what, why, who and how? PharmacoEconomics DOI: 10.1007/s40273-019-00819-z [PDF (post-print)] (with Arnold, R., Bryan, S., Clarke, P., Ekins, S., Hatswell, A., Hawkins, N., Langham, S., Marshall, D., Sadatsafavi, M., Sullivan, W., Wilson, E.C.F., and Wrightson, T.)

Individualised screening for diabetic retinopathy: the ISDR study—rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening. BMJ Open 9(6), e025788. DOI: 10.1136/bmjopen-2018-025788 (with Broadbent, D.M, Wang, A., Howard, L., Williams, A.E., Howlin, S.U., Appelbe, D., Moitt, T., Cheyne, C.P., Mobayen Rahni, M., Kelly, J., Collins, J., García-Fiñana, M., Stratton, I.M., James, M. and Harding, S.P. for the ISDR Study Group)

How should we measure quality of life impact in rare disease? Recent learnings in spinal muscular atrophy. OHE Briefing. [RePEc] (with Garau, M.)

2018

R&D, competition and diffusion of innovation in the EU: the case of hepatitis C. OHE Research Paper. [RePEc] (with Berdud, M., Garau, M., Neri, M., O’Neill, P. and Towse, A.)

Barriers to Uptake of Minimal Access Surgery in the United Kingdom. OHE Consulting Report. [RePEc] (with Cole, A., O’Neill, P., and Lorgelly, P.)

The impact of new medicines in the NHS: 70 Years of innovation. OHE Consulting Report. [RePEc] (with O’Neill, P. and Lorgelly, P.)

2017

Model registration: a call to action. PharmacoEconomics – Open 1(2), 73-77. DOI: 10.1007/s41669-017-0019-2 (with Wrightson, T.)

2016

Stratifying the NHS Diabetic Eye Screening Programme: into the unknown? Diabetic Medicine 33(12), 1612-1614. DOI: 10.1111/dme.13192 [PDF (pre-print)] (with James, M., Broadbent, D. and Harding, S.P.)

Cognitive Behaviour Therapy for Long-term Frequent Attenders in Primary Care: A Feasibility Case Series and Treatment Development Study. British Journal of General Practice 66(651), e729-e736. DOI: 10.3399/bjgp16X686569 (with Malins, S., Kai, J., Atha, C., Avery, A., Guo, B., James, M., Patel, S., Stubley, M. and Morriss, R.)

Efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression: a randomised controlled trial. The Lancet Psychiatr 3(9), 821-831. DOI: 10.1016/S2215-0366(16)30143-2 [PDF (post-print)] (with Morriss, R., Garland, A., Nixon, N., Guo, B., James, M., Kaylor-Hughes, C., Moore, R., Ramana, R., Sweeney, T., Dalgleish, T. and the NIHR CLAHRC Specialist Mood Disorder Study Group)

Effectiveness and cost-effectiveness of a brief school-based group programme for parents of children at risk of ADHD: a cluster randomised controlled trial. Child: Care, Health and Development 42(4), 521-533. DOI: 10.1111/cch.12349 [PDF (post-print)] (with Sayal, K., Taylor, J.A., Valentine, A., Guo, B., Sellman, E., James, M., Hollis, C. and Daley, D.)

A randomised controlled trial of laser scanning and casting for the construction of ankle foot orthoses. Prosthetics and Orthotics International 40(2), 253-261. DOI: 10.1177/0309364614550263 [PDF (post-print)] (with Roberts, A., Wales, J., Smith, H., Jones, P. and James, M.)

Identifying objects of value at the end of life. In J. Round (Eds.) Care at the End of Life: An Economic Perspective (pp. 103-122). Springer International Publishing. DOI: 10.1007/978-3-319-28267-1_8 [PDF (pre-print)]

Long term economic evaluation of interventions targeting multiple mental health conditions: protocol for a rapid review of methods. PeerJ Preprints 4:e1988v1. DOI: 10.7287/peerj.preprints.1988v1 (with Canaway, A.G.)

2015

Clinical characteristics of persistent frequent attenders in primary care: case control study. Family Practice, 32(6), 624-630. DOI: 10.1093/fampra/cmv076 [institutional repository] (with Morriss, R., Patel, S., Kai, J., Atha, C., Avery, A., Guo, B., James, M., Malins, S. and Stubley, M.)

Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis. Systematic Reviews, 4:15. DOI: 10.1186/s13643-015-0006-6 (with Tosh, J.C., Cheyne, C.P., Broadbent, D. and James, M.)

2014

An introduction to economic evaluation in occupational therapy: cost-effectiveness of pre-discharge home visits after stroke (HOVIS). British Journal of Occupational Therapy, 77(7), 330-335. DOI: 10.4276/030802214X14044755581664 [PDF (post-print)] (with James, M., Whitehead, P. and Drummond, A.E.R.)

2013

Cost implications of treatment non-completion in a forensic personality disorder service. Criminal Behaviour and Mental Health, 23(5), 321-335. DOI: 10.1002/cbm.1866 (with James, M., Huband, N., Geelan, S. and McMurran, M.)

Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469-776. The European Journal of Health Economics, 14(4), 703-705. DOI: 10.1007/s10198-013-0466-3 [PDF (pre-print)] (with Whitehurst, D.G.T. and Street, A.)

Occupational therapy pre-discharge home visits for patients with a stroke (HOVIS): results of a feasibility randomized controlled trial. Clinical Rehabilitation, 27(5), 387-397. DOI: 10.1177/0269215512462145 (with Drummond, A.E.R., Whitehead, P., Fellows, K., Sprigg, N., Edwards, C. and Lincoln, N.B.)

Happy and healthy: a joint model of health and life satisfaction. [RePEc] (with Hernández-Alava, M. and Wailoo, A.)

The relationship between individual risk and cost-effectiveness in screening interventions. [RePEc] (with James, M. and Whynes, D.)

Generic preference based measures: how economists measure health benefit. Advances in Clinical Neuroscience and Rehabilitation 13(5), 23-24. [ACNR website]

2012

Protocol Evaluating the effectiveness of a school-based group programme for parents of children at risk of ADHD: the “PArents, Teachers and CHildren WORKing Together (PATCHWORK)” cluster RCT protocol. BMJ Open, 2(5), 1–8. DOI: 10.1136/bmjopen-2012-001783 (with Sayal, K., Daley, D., James, M., Yang, M., Batty, M.J., Taylor, J.A., Pass, S., Sellman, E., Valentine, A. and Hollis, C.)